287 related articles for article (PubMed ID: 15948389)
1. [Treatment for the elderly hypertensive patient with renal insufficiency].
Kobayashi K; Kanno Y; Suzuki H
Nihon Rinsho; 2005 Jun; 63(6):1047-51. PubMed ID: 15948389
[TBL] [Abstract][Full Text] [Related]
2. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].
Ishimitsu T
Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434
[TBL] [Abstract][Full Text] [Related]
3. [Antihypertensive treatment guideline for elderly hypertension].
Ogihara T
Nihon Rinsho; 2001 May; 59(5):919-26. PubMed ID: 11391992
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
5. [Perfect 24-hr blood pressure control using self-measured blood pressure and ambulatory blood pressure monitoring in chronic kidney disease].
Kario K
Nihon Jinzo Gakkai Shi; 2009; 51(4):465-70. PubMed ID: 19601555
[No Abstract] [Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
7. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
8. [Management of elderly hypertensive individuals with hyperlipidemia].
Kozaki K
Nihon Rinsho; 2005 Jun; 63(6):1061-6. PubMed ID: 15948391
[TBL] [Abstract][Full Text] [Related]
9. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
Schmieder RE
Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
[TBL] [Abstract][Full Text] [Related]
10. Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?
Wong J; Molyneaux L; Constantino M; Twigg SM; Yue DK
Diabetes Obes Metab; 2010 Dec; 12(12):1072-8. PubMed ID: 20977578
[TBL] [Abstract][Full Text] [Related]
11. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
[TBL] [Abstract][Full Text] [Related]
12. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
13. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
14. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
15. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
16. Treatment of diabetic hypertension.
Bell DS
Diabetes Obes Metab; 2009 May; 11(5):433-44. PubMed ID: 19236440
[TBL] [Abstract][Full Text] [Related]
17. Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Ohishi M; Takeya Y; Tatara Y; Yamamoto K; Onishi M; Maekawa Y; Kamide K; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1150-4. PubMed ID: 20703230
[TBL] [Abstract][Full Text] [Related]
18. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
19. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
[TBL] [Abstract][Full Text] [Related]
20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
